Combination Therapy With Tofacitinib and IL-12/23, IL-23, or IL-17A Inhibition for the Treatment of Refractory Psoriatic Arthritis A Case Series-MedSci.cn

Combination Therapy With Tofacitinib and IL-12/23, IL-23, or IL-17A Inhibition for the Treatment of Refractory Psoriatic Arthritis A Case Series

Shurey, M; Yip, A; Ziouzina, O; Chan, J; Dutz, JP

Shurey, M (通讯作者)，Univ British Columbia, Dept Internal Med, 2775 Laurel St,10th Floor, Vancouver, BC V5V 1M9, Canada.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022; 28 (2): E626

科室
- - 订阅+
  - 更多科室
工具
服务